Showing results (651-660 of 750) with videos related to
Sort By:
Pageof 75
European Journal of Clinical Pharmacology|April 17, 1999
Utilization of cardiovascular drugs (blood pressure lowering drugs, lipid lowering drugs and nitrates) and mortality from ischaemic heart disease and stroke. An ecological analysis based on Sweden's municipalitiesJ Merlo, G Lindberg, U Lindblad, et al.European Journal of Clinical Pharmacology|January 1, 1987
Lack of primary effect of sulphonylurea (glipizide) on plasma lipoproteins and insulin action in former type 2 diabetics with attenuated insulin secretionG Sartor, D Ursing, P Nilsson-Ehle, et al.Acta Endocrinologica|February 1, 1987
3,4-Dihydroxypyridine: a potential antithyroid drugB Hallengren, M P Hegarty, A Forsgren, et al.Clinical Pharmacokinetics|May 1, 1986
Reduction of paracetamol and aspirin metabolism during viral hepatitisC Jorup-Rönström, B Beermann, E Wåhlin-Boll, et al.Diabetes Care|August 1, 1990
Will sulfonylurea treatment of impaired glucose tolerance delay development and complications of NIDDM?A Melander, P O Bitzén, G Sartor, et al.European Journal of Clinical Pharmacology|January 1, 1992
Long-term effects of glipizide on insulin secretion and blood glucose control in patients with non-insulin-dependent diabetes mellitusP O Bitzén, A Melander, B Scherstén, et al.Dementia and Geriatric Cognitive Disorders Extra|November 3, 2018
The Impact of Using Measurements of Electrodermal Activity in the Assessment of Problematic Behaviour in DementiaCatharina A Melander, Basel Kikhia, Malin Olsson, et al.Cell and Tissue Research|March 16, 1977
Immunohistochemical localization of neurotensin in endocrine cells of the gutF Sundler, R Håkanson, R A Hammer, et al.Digestive Diseases and Sciences|December 1, 1986
Regulatory peptides in lower esophageal sphincter of pig and manS Aggestrup, R Uddman, S L Jensen, et al.Gut|August 1, 1983
Peptide-containing nerve fibres in the gut wall in Crohn's diseaseK Sjölund, O B Schaffalitzky, D E Muckadell, et al.Pageof 75